Myomo, Inc.
Myomo, Inc. MYO Peers
See (MYO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MYO | $2.12 | -4.30% | 78.3M | -15.54 | -$0.14 | N/A |
| ABT | $131.94 | -0.96% | 232.4B | 17.37 | $7.69 | +1.71% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $103.18 | +0.21% | 153.6B | 75.81 | $1.37 | N/A |
| SYK | $389.24 | -0.72% | 150.9B | 53.34 | $7.40 | +0.84% |
| MDT | $89.98 | +1.10% | 114.5B | 24.76 | $3.61 | +3.92% |
| EW | $77.89 | +0.91% | 46.2B | 32.55 | $2.42 | N/A |
| DXCM | $83.25 | -1.91% | 33.5B | 64.26 | $1.33 | N/A |
| PHG | $24.04 | -0.37% | 22.8B | 79.58 | $0.31 | +3.60% |
| STE | $228.09 | -1.38% | 22.7B | 37.44 | $6.16 | +1.21% |
Stock Comparison
MYO vs ABT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ABT has a market cap of 232.4B. Regarding current trading prices, MYO is priced at $2.12, while ABT trades at $131.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ABT's P/E ratio is 17.37. In terms of profitability, MYO's ROE is -0.36%, compared to ABT's ROE of +0.31%. Regarding short-term risk, MYO is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BSX-PA Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, MYO is priced at $2.12, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, MYO's ROE is -0.36%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BSX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BSX has a market cap of 153.6B. Regarding current trading prices, MYO is priced at $2.12, while BSX trades at $103.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BSX's P/E ratio is 75.81. In terms of profitability, MYO's ROE is -0.36%, compared to BSX's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SYK Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SYK has a market cap of 150.9B. Regarding current trading prices, MYO is priced at $2.12, while SYK trades at $389.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SYK's P/E ratio is 53.34. In terms of profitability, MYO's ROE is -0.36%, compared to SYK's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs MDT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, MDT has a market cap of 114.5B. Regarding current trading prices, MYO is priced at $2.12, while MDT trades at $89.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas MDT's P/E ratio is 24.76. In terms of profitability, MYO's ROE is -0.36%, compared to MDT's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs EW Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, EW has a market cap of 46.2B. Regarding current trading prices, MYO is priced at $2.12, while EW trades at $77.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas EW's P/E ratio is 32.55. In terms of profitability, MYO's ROE is -0.36%, compared to EW's ROE of +0.49%. Regarding short-term risk, MYO is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs DXCM Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, DXCM has a market cap of 33.5B. Regarding current trading prices, MYO is priced at $2.12, while DXCM trades at $83.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas DXCM's P/E ratio is 64.26. In terms of profitability, MYO's ROE is -0.36%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, MYO is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PHG Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PHG has a market cap of 22.8B. Regarding current trading prices, MYO is priced at $2.12, while PHG trades at $24.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PHG's P/E ratio is 79.58. In terms of profitability, MYO's ROE is -0.36%, compared to PHG's ROE of +0.03%. Regarding short-term risk, MYO is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs STE Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, STE has a market cap of 22.7B. Regarding current trading prices, MYO is priced at $2.12, while STE trades at $228.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas STE's P/E ratio is 37.44. In terms of profitability, MYO's ROE is -0.36%, compared to STE's ROE of +0.09%. Regarding short-term risk, MYO is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PODD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PODD has a market cap of 20.9B. Regarding current trading prices, MYO is priced at $2.12, while PODD trades at $291.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PODD's P/E ratio is 54.19. In terms of profitability, MYO's ROE is -0.36%, compared to PODD's ROE of +0.35%. Regarding short-term risk, MYO is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ZBH Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ZBH has a market cap of 18.8B. Regarding current trading prices, MYO is priced at $2.12, while ZBH trades at $94.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ZBH's P/E ratio is 21.14. In terms of profitability, MYO's ROE is -0.36%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, MYO is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ABMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, MYO is priced at $2.12, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ABMD's P/E ratio is 65.36. In terms of profitability, MYO's ROE is -0.36%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ALGN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ALGN has a market cap of 14.8B. Regarding current trading prices, MYO is priced at $2.12, while ALGN trades at $201.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ALGN's P/E ratio is 37.24. In terms of profitability, MYO's ROE is -0.36%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, MYO is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SNN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SNN has a market cap of 13.6B. Regarding current trading prices, MYO is priced at $2.12, while SNN trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SNN's P/E ratio is 33.05. In terms of profitability, MYO's ROE is -0.36%, compared to SNN's ROE of +0.08%. Regarding short-term risk, MYO is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SWAV Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, MYO is priced at $2.12, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SWAV's P/E ratio is 78.76. In terms of profitability, MYO's ROE is -0.36%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, MYO is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PEN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PEN has a market cap of 9.4B. Regarding current trading prices, MYO is priced at $2.12, while PEN trades at $237.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PEN's P/E ratio is 225.76. In terms of profitability, MYO's ROE is -0.36%, compared to PEN's ROE of +0.04%. Regarding short-term risk, MYO is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs GMED Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, GMED has a market cap of 7.8B. Regarding current trading prices, MYO is priced at $2.12, while GMED trades at $57.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas GMED's P/E ratio is 42.79. In terms of profitability, MYO's ROE is -0.36%, compared to GMED's ROE of +0.05%. Regarding short-term risk, MYO is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BIO Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BIO has a market cap of 7.1B. Regarding current trading prices, MYO is priced at $2.12, while BIO trades at $257.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BIO's P/E ratio is -3.40. In terms of profitability, MYO's ROE is -0.36%, compared to BIO's ROE of -0.32%. Regarding short-term risk, MYO is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BIO-B Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, MYO is priced at $2.12, while BIO-B trades at $257.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BIO-B's P/E ratio is -3.27. In terms of profitability, MYO's ROE is -0.36%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, MYO is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BRKR Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BRKR has a market cap of 6.6B. Regarding current trading prices, MYO is priced at $2.12, while BRKR trades at $43.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BRKR's P/E ratio is 83.81. In terms of profitability, MYO's ROE is -0.36%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, MYO is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs GKOS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, GKOS has a market cap of 6.1B. Regarding current trading prices, MYO is priced at $2.12, while GKOS trades at $103.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas GKOS's P/E ratio is -46.94. In terms of profitability, MYO's ROE is -0.36%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, MYO is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs NARI Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, MYO is priced at $2.12, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas NARI's P/E ratio is -59.24. In terms of profitability, MYO's ROE is -0.36%, compared to NARI's ROE of -0.18%. Regarding short-term risk, MYO is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs IRTC Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, IRTC has a market cap of 4.3B. Regarding current trading prices, MYO is priced at $2.12, while IRTC trades at $135.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas IRTC's P/E ratio is -43.23. In terms of profitability, MYO's ROE is -0.36%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, MYO is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ITGR Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, MYO is priced at $2.12, while ITGR trades at $120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ITGR's P/E ratio is 56.93. In terms of profitability, MYO's ROE is -0.36%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, MYO is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs TMDX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, TMDX has a market cap of 4.2B. Regarding current trading prices, MYO is priced at $2.12, while TMDX trades at $114.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas TMDX's P/E ratio is 87.87. In terms of profitability, MYO's ROE is -0.36%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, MYO is less volatile compared to TMDX. This indicates potentially lower risk in terms of short-term price fluctuations for MYO.
MYO vs INSP Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, INSP has a market cap of 4.1B. Regarding current trading prices, MYO is priced at $2.12, while INSP trades at $132.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas INSP's P/E ratio is 63.89. In terms of profitability, MYO's ROE is -0.36%, compared to INSP's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AXNX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, MYO is priced at $2.12, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AXNX's P/E ratio is -709.80. In terms of profitability, MYO's ROE is -0.36%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, MYO is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PRCT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PRCT has a market cap of 3.3B. Regarding current trading prices, MYO is priced at $2.12, while PRCT trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PRCT's P/E ratio is -34.99. In terms of profitability, MYO's ROE is -0.36%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, MYO is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs LIVN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, LIVN has a market cap of 2.5B. Regarding current trading prices, MYO is priced at $2.12, while LIVN trades at $45.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas LIVN's P/E ratio is -11.47. In terms of profitability, MYO's ROE is -0.36%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, MYO is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs NUVA Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, MYO is priced at $2.12, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas NUVA's P/E ratio is 75.00. In terms of profitability, MYO's ROE is -0.36%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, MYO is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs UFPT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, MYO is priced at $2.12, while UFPT trades at $244.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas UFPT's P/E ratio is 30.95. In terms of profitability, MYO's ROE is -0.36%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, MYO is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ATEC Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ATEC has a market cap of 1.7B. Regarding current trading prices, MYO is priced at $2.12, while ATEC trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ATEC's P/E ratio is -10.16. In terms of profitability, MYO's ROE is -0.36%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, MYO is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CNMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CNMD has a market cap of 1.7B. Regarding current trading prices, MYO is priced at $2.12, while CNMD trades at $51.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CNMD's P/E ratio is 14.08. In terms of profitability, MYO's ROE is -0.36%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, MYO is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AORT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, MYO is priced at $2.12, while AORT trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AORT's P/E ratio is -63.97. In terms of profitability, MYO's ROE is -0.36%, compared to AORT's ROE of -0.07%. Regarding short-term risk, MYO is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ESTA Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ESTA has a market cap of 1.3B. Regarding current trading prices, MYO is priced at $2.12, while ESTA trades at $45.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ESTA's P/E ratio is -14.71. In terms of profitability, MYO's ROE is -0.36%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, MYO is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs HSKA Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, MYO is priced at $2.12, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas HSKA's P/E ratio is -62.49. In terms of profitability, MYO's ROE is -0.36%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, MYO is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AHCO Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, MYO is priced at $2.12, while AHCO trades at $9.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AHCO's P/E ratio is 16.26. In terms of profitability, MYO's ROE is -0.36%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, MYO is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SILK Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $2.12, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SILK's P/E ratio is -18.96. In terms of profitability, MYO's ROE is -0.36%, compared to SILK's ROE of -0.29%. Regarding short-term risk, MYO is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs FNA Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $2.12, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas FNA's P/E ratio is -19.83. In terms of profitability, MYO's ROE is -0.36%, compared to FNA's ROE of -0.36%. Regarding short-term risk, MYO is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs TNDM Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $2.12, while TNDM trades at $15.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas TNDM's P/E ratio is -5.80. In terms of profitability, MYO's ROE is -0.36%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, MYO is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs INMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, INMD has a market cap of 1.1B. Regarding current trading prices, MYO is priced at $2.12, while INMD trades at $14.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas INMD's P/E ratio is 6.80. In terms of profitability, MYO's ROE is -0.36%, compared to INMD's ROE of +0.25%. Regarding short-term risk, MYO is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SSII Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SSII has a market cap of 1B. Regarding current trading prices, MYO is priced at $2.12, while SSII trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SSII's P/E ratio is -66.50. In terms of profitability, MYO's ROE is -0.36%, compared to SSII's ROE of -1.05%. Regarding short-term risk, MYO is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs IART Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, IART has a market cap of 1B. Regarding current trading prices, MYO is priced at $2.12, while IART trades at $12.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas IART's P/E ratio is -34.68. In terms of profitability, MYO's ROE is -0.36%, compared to IART's ROE of -0.03%. Regarding short-term risk, MYO is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CSII Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, MYO is priced at $2.12, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CSII's P/E ratio is -20.83. In terms of profitability, MYO's ROE is -0.36%, compared to CSII's ROE of -0.14%. Regarding short-term risk, MYO is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SIBN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SIBN has a market cap of 800.7M. Regarding current trading prices, MYO is priced at $2.12, while SIBN trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SIBN's P/E ratio is -29.82. In terms of profitability, MYO's ROE is -0.36%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, MYO is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs IRMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, IRMD has a market cap of 756.2M. Regarding current trading prices, MYO is priced at $2.12, while IRMD trades at $58.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas IRMD's P/E ratio is 38.37. In terms of profitability, MYO's ROE is -0.36%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, MYO is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CRY Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, MYO is priced at $2.12, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CRY's P/E ratio is 425.71. In terms of profitability, MYO's ROE is -0.36%, compared to CRY's ROE of -0.07%. Regarding short-term risk, MYO is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CBLL Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CBLL has a market cap of 605.8M. Regarding current trading prices, MYO is priced at $2.12, while CBLL trades at $16.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CBLL's P/E ratio is -13.41. In terms of profitability, MYO's ROE is -0.36%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, MYO is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs APEN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, MYO is priced at $2.12, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas APEN's P/E ratio is -9.43. In terms of profitability, MYO's ROE is -0.36%, compared to APEN's ROE of -0.85%. Regarding short-term risk, MYO is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AVNS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AVNS has a market cap of 567M. Regarding current trading prices, MYO is priced at $2.12, while AVNS trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AVNS's P/E ratio is -1.48. In terms of profitability, MYO's ROE is -0.36%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, MYO is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs KIDS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, KIDS has a market cap of 556.1M. Regarding current trading prices, MYO is priced at $2.12, while KIDS trades at $21.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas KIDS's P/E ratio is -12.76. In terms of profitability, MYO's ROE is -0.36%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, MYO is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AXGN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AXGN has a market cap of 549.7M. Regarding current trading prices, MYO is priced at $2.12, while AXGN trades at $12.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AXGN's P/E ratio is -75.44. In terms of profitability, MYO's ROE is -0.36%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, MYO is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SMLR Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SMLR has a market cap of 512.9M. Regarding current trading prices, MYO is priced at $2.12, while SMLR trades at $45.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SMLR's P/E ratio is -19.24. In terms of profitability, MYO's ROE is -0.36%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, MYO is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BVS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BVS has a market cap of 491M. Regarding current trading prices, MYO is priced at $2.12, while BVS trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BVS's P/E ratio is -15.42. In terms of profitability, MYO's ROE is -0.36%, compared to BVS's ROE of -0.21%. Regarding short-term risk, MYO is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BFLY-WT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BFLY-WT has a market cap of 478.3M. Regarding current trading prices, MYO is priced at $2.12, while BFLY-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, MYO's ROE is -0.36%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, MYO is more volatile compared to BFLY-WT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BFLY Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BFLY has a market cap of 463.7M. Regarding current trading prices, MYO is priced at $2.12, while BFLY trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BFLY's P/E ratio is -6.25. In terms of profitability, MYO's ROE is -0.36%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, MYO is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CTKB Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CTKB has a market cap of 450.9M. Regarding current trading prices, MYO is priced at $2.12, while CTKB trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CTKB's P/E ratio is -39.56. In terms of profitability, MYO's ROE is -0.36%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, MYO is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PACB Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PACB has a market cap of 450.1M. Regarding current trading prices, MYO is priced at $2.12, while PACB trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PACB's P/E ratio is -0.54. In terms of profitability, MYO's ROE is -0.36%, compared to PACB's ROE of -1.70%. Regarding short-term risk, MYO is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs OFIX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, OFIX has a market cap of 445.1M. Regarding current trading prices, MYO is priced at $2.12, while OFIX trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas OFIX's P/E ratio is -3.07. In terms of profitability, MYO's ROE is -0.36%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, MYO is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SRDX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SRDX has a market cap of 443.7M. Regarding current trading prices, MYO is priced at $2.12, while SRDX trades at $30.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SRDX's P/E ratio is -22.16. In terms of profitability, MYO's ROE is -0.36%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, MYO is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs TMCI Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, TMCI has a market cap of 391.3M. Regarding current trading prices, MYO is priced at $2.12, while TMCI trades at $5.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas TMCI's P/E ratio is -7.32. In terms of profitability, MYO's ROE is -0.36%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, MYO is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SENS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SENS has a market cap of 377.1M. Regarding current trading prices, MYO is priced at $2.12, while SENS trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SENS's P/E ratio is -4.54. In terms of profitability, MYO's ROE is -0.36%, compared to SENS's ROE of -7.46%. Regarding short-term risk, MYO is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs OM Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, OM has a market cap of 366.1M. Regarding current trading prices, MYO is priced at $2.12, while OM trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas OM's P/E ratio is -0.72. In terms of profitability, MYO's ROE is -0.36%, compared to OM's ROE of -1.45%. Regarding short-term risk, MYO is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs VREX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, VREX has a market cap of 354.4M. Regarding current trading prices, MYO is priced at $2.12, while VREX trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas VREX's P/E ratio is -8.29. In terms of profitability, MYO's ROE is -0.36%, compared to VREX's ROE of -0.08%. Regarding short-term risk, MYO is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs RXST Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, RXST has a market cap of 343.8M. Regarding current trading prices, MYO is priced at $2.12, while RXST trades at $8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas RXST's P/E ratio is -12.82. In terms of profitability, MYO's ROE is -0.36%, compared to RXST's ROE of -0.10%. Regarding short-term risk, MYO is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CLPT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CLPT has a market cap of 338M. Regarding current trading prices, MYO is priced at $2.12, while CLPT trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CLPT's P/E ratio is -15.74. In terms of profitability, MYO's ROE is -0.36%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, MYO is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs NPCE Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, NPCE has a market cap of 333.2M. Regarding current trading prices, MYO is priced at $2.12, while NPCE trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas NPCE's P/E ratio is -12.39. In terms of profitability, MYO's ROE is -0.36%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, MYO is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs NNOX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, NNOX has a market cap of 330M. Regarding current trading prices, MYO is priced at $2.12, while NNOX trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas NNOX's P/E ratio is -5.69. In terms of profitability, MYO's ROE is -0.36%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, MYO is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SNWV Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SNWV has a market cap of 308.9M. Regarding current trading prices, MYO is priced at $2.12, while SNWV trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SNWV's P/E ratio is -5.79. In terms of profitability, MYO's ROE is -0.36%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, MYO is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CATX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CATX has a market cap of 303.2M. Regarding current trading prices, MYO is priced at $2.12, while CATX trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CATX's P/E ratio is -3.32. In terms of profitability, MYO's ROE is -0.36%, compared to CATX's ROE of -0.27%. Regarding short-term risk, MYO is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CERS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CERS has a market cap of 297.3M. Regarding current trading prices, MYO is priced at $2.12, while CERS trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CERS's P/E ratio is -15.55. In terms of profitability, MYO's ROE is -0.36%, compared to CERS's ROE of -0.35%. Regarding short-term risk, MYO is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PTHL Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PTHL has a market cap of 291.3M. Regarding current trading prices, MYO is priced at $2.12, while PTHL trades at $20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PTHL's P/E ratio is -408.80. In terms of profitability, MYO's ROE is -0.36%, compared to PTHL's ROE of -0.30%. Regarding short-term risk, MYO is more volatile compared to PTHL. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs VMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, VMD has a market cap of 275.9M. Regarding current trading prices, MYO is priced at $2.12, while VMD trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas VMD's P/E ratio is 22.52. In terms of profitability, MYO's ROE is -0.36%, compared to VMD's ROE of +0.10%. Regarding short-term risk, MYO is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ZIMV Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ZIMV has a market cap of 262.5M. Regarding current trading prices, MYO is priced at $2.12, while ZIMV trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ZIMV's P/E ratio is -10.22. In terms of profitability, MYO's ROE is -0.36%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, MYO is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs MASS Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, MASS has a market cap of 258.6M. Regarding current trading prices, MYO is priced at $2.12, while MASS trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas MASS's P/E ratio is -3.25. In terms of profitability, MYO's ROE is -0.36%, compared to MASS's ROE of -0.13%. Regarding short-term risk, MYO is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs MXCT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, MXCT has a market cap of 243.4M. Regarding current trading prices, MYO is priced at $2.12, while MXCT trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas MXCT's P/E ratio is -5.72. In terms of profitability, MYO's ROE is -0.36%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, MYO is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BWAY Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BWAY has a market cap of 239.1M. Regarding current trading prices, MYO is priced at $2.12, while BWAY trades at $12.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BWAY's P/E ratio is 57.52. In terms of profitability, MYO's ROE is -0.36%, compared to BWAY's ROE of +0.07%. Regarding short-term risk, MYO is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs TCMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, TCMD has a market cap of 238.5M. Regarding current trading prices, MYO is priced at $2.12, while TCMD trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas TCMD's P/E ratio is 15.55. In terms of profitability, MYO's ROE is -0.36%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, MYO is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs QTRX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, QTRX has a market cap of 227.5M. Regarding current trading prices, MYO is priced at $2.12, while QTRX trades at $5.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas QTRX's P/E ratio is -4.72. In terms of profitability, MYO's ROE is -0.36%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, MYO is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs NVRO Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, MYO is priced at $2.12, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas NVRO's P/E ratio is -1.91. In terms of profitability, MYO's ROE is -0.36%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, MYO is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs EYES Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, MYO is priced at $2.12, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas EYES's P/E ratio is N/A. In terms of profitability, MYO's ROE is -0.36%, compared to EYES's ROE of -0.26%. Regarding short-term risk, MYO is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs INGN Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, INGN has a market cap of 196.5M. Regarding current trading prices, MYO is priced at $2.12, while INGN trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas INGN's P/E ratio is -6.36. In terms of profitability, MYO's ROE is -0.36%, compared to INGN's ROE of -0.15%. Regarding short-term risk, MYO is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs TLSI Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, TLSI has a market cap of 189.9M. Regarding current trading prices, MYO is priced at $2.12, while TLSI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas TLSI's P/E ratio is -4.55. In terms of profitability, MYO's ROE is -0.36%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, MYO is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs PROF Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, PROF has a market cap of 182.4M. Regarding current trading prices, MYO is priced at $2.12, while PROF trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas PROF's P/E ratio is -5.02. In terms of profitability, MYO's ROE is -0.36%, compared to PROF's ROE of -0.70%. Regarding short-term risk, MYO is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs CVRX Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, CVRX has a market cap of 181.7M. Regarding current trading prices, MYO is priced at $2.12, while CVRX trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas CVRX's P/E ratio is -3.26. In terms of profitability, MYO's ROE is -0.36%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, MYO is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs SGHT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, SGHT has a market cap of 177.6M. Regarding current trading prices, MYO is priced at $2.12, while SGHT trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas SGHT's P/E ratio is -3.51. In terms of profitability, MYO's ROE is -0.36%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, MYO is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ANIK Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ANIK has a market cap of 169.2M. Regarding current trading prices, MYO is priced at $2.12, while ANIK trades at $11.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ANIK's P/E ratio is -15.73. In terms of profitability, MYO's ROE is -0.36%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, MYO is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ELMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ELMD has a market cap of 168.5M. Regarding current trading prices, MYO is priced at $2.12, while ELMD trades at $19.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ELMD's P/E ratio is 25.43. In terms of profitability, MYO's ROE is -0.36%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, MYO is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BSGM Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BSGM has a market cap of 160.4M. Regarding current trading prices, MYO is priced at $2.12, while BSGM trades at $5.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BSGM's P/E ratio is -11.08. In terms of profitability, MYO's ROE is -0.36%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, MYO is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for MYO.
MYO vs RCEL Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, RCEL has a market cap of 157M. Regarding current trading prices, MYO is priced at $2.12, while RCEL trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas RCEL's P/E ratio is -2.71. In terms of profitability, MYO's ROE is -0.36%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, MYO is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs LNSR Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, LNSR has a market cap of 156.1M. Regarding current trading prices, MYO is priced at $2.12, while LNSR trades at $13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas LNSR's P/E ratio is -2.70. In terms of profitability, MYO's ROE is -0.36%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, MYO is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs RPID Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, RPID has a market cap of 148.4M. Regarding current trading prices, MYO is priced at $2.12, while RPID trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas RPID's P/E ratio is -3.29. In terms of profitability, MYO's ROE is -0.36%, compared to RPID's ROE of -0.56%. Regarding short-term risk, MYO is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs OWLT Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, OWLT has a market cap of 145.4M. Regarding current trading prices, MYO is priced at $2.12, while OWLT trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas OWLT's P/E ratio is -5.64. In terms of profitability, MYO's ROE is -0.36%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, MYO is more volatile compared to OWLT. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs LUCD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, LUCD has a market cap of 126.6M. Regarding current trading prices, MYO is priced at $2.12, while LUCD trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas LUCD's P/E ratio is -1.00. In terms of profitability, MYO's ROE is -0.36%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, MYO is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs AVR Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, AVR has a market cap of 125.3M. Regarding current trading prices, MYO is priced at $2.12, while AVR trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas AVR's P/E ratio is -0.97. In terms of profitability, MYO's ROE is -0.36%, compared to AVR's ROE of -2.92%. Regarding short-term risk, MYO is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs BDMD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, BDMD has a market cap of 124.4M. Regarding current trading prices, MYO is priced at $2.12, while BDMD trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas BDMD's P/E ratio is 7.11. In terms of profitability, MYO's ROE is -0.36%, compared to BDMD's ROE of +0.32%. Regarding short-term risk, MYO is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs MGRM Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, MGRM has a market cap of 119.2M. Regarding current trading prices, MYO is priced at $2.12, while MGRM trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas MGRM's P/E ratio is -6.68. In terms of profitability, MYO's ROE is -0.36%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, MYO is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs LUNG Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, LUNG has a market cap of 107.1M. Regarding current trading prices, MYO is priced at $2.12, while LUNG trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas LUNG's P/E ratio is -1.85. In terms of profitability, MYO's ROE is -0.36%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, MYO is more volatile compared to LUNG. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.
MYO vs ICAD Comparison
MYO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYO stands at 78.3M. In comparison, ICAD has a market cap of 106.4M. Regarding current trading prices, MYO is priced at $2.12, while ICAD trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYO currently has a P/E ratio of -15.54, whereas ICAD's P/E ratio is -20.39. In terms of profitability, MYO's ROE is -0.36%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, MYO is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for MYO.